Habib Zarredar Selected Research

AZD 8931

1/2019	Synergistic Effect of Novel EGFR Inhibitor AZD8931 and p38α siRNA in Lung Adenocarcinoma Cancer Cells.
1/2019	Combination therapy with KRAS siRNA and EGFR inhibitor AZD8931 suppresses lung cancer cell growth in vitro.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Habib Zarredar Research Topics

Disease

15	Neoplasms (Cancer) 12/2022 - 10/2014
8	Lung Neoplasms (Lung Cancer) 05/2022 - 01/2018
3	Carcinogenesis 12/2022 - 01/2018
3	Adenocarcinoma of Lung 01/2019 - 01/2019
2	Colorectal Neoplasms (Colorectal Cancer) 12/2022 - 09/2022
2	COVID-19 08/2022 - 12/2021
2	Communicable Diseases (Infectious Diseases) 12/2021 - 01/2014
2	Sarcoma (Soft Tissue Sarcoma) 01/2019 - 01/2019
2	Breast Neoplasms (Breast Cancer) 09/2018 - 01/2018
1	Neuroblastoma 03/2022
1	Infections 12/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019
1	Rheumatoid Arthritis 06/2018
1	Autoimmune Diseases (Autoimmune Disease) 06/2018
1	Neoplasm Metastasis (Metastasis) 01/2018
1	Circulating Neoplastic Cells 01/2018
1	Ascites 01/2018
1	Fibrosarcoma 10/2014

Drug/Important Bio-Agent (IBA)

4	Small Interfering RNA (siRNA)IBA 09/2022 - 01/2018
3	MicroRNAs (MicroRNA)IBA 12/2022 - 01/2018
3	Biomarkers (Surrogate Marker)IBA 12/2022 - 01/2021
2	MicronutrientsIBA 08/2022 - 12/2021
2	AZD 8931IBA 01/2019 - 01/2019
1	Thymidylate SynthaseIBA 12/2022
1	SolventsIBA 03/2022
1	Biological ProductsIBA 01/2022
1	AntioxidantsIBA 12/2021
1	VitaminsIBA 12/2021
1	Plant ExtractsIBA 04/2021
1	Long Noncoding RNAIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2019
1	Mitogen-Activated Protein KinasesIBA 01/2019
1	ErbB Receptors (EGF Receptor)IBA 01/2019
1	SurvivinIBA 09/2018
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2018
1	OligonucleotidesIBA 01/2018
1	adecatumumabIBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	Glycoproteins (Glycoprotein)IBA 01/2018
1	AntigensIBA 01/2018
1	Monoclonal AntibodiesIBA 01/2018
1	AntibodiesIBA 01/2018
1	Epithelial Cell Adhesion MoleculeIBA 01/2018
1	AntagomirsIBA 01/2018
1	catumaxomabIBA 01/2018
1	Immunomodulating AgentsIBA 10/2014
1	Thalidomide (Thalomid)FDA Link 10/2014
1	VaccinesIBA 01/2014

Therapy/Procedure

11	Therapeutics 09/2022 - 10/2014
2	Drug Therapy (Chemotherapy) 01/2018 - 10/2014
1	Aftercare (After-Treatment) 09/2022
1	Adjuvant Chemotherapy 01/2019
1	Radiotherapy 10/2014